Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07467239) titled 'A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds' on March 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Samyang Biopharmaceuticals Corporation
Condition:
Nasolabial Folds, Wrinkles
Intervention:
Device: DMFI300
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 2, 2026
Target Sample Size: 30
Countries of Recruitment:
Spain
To know more, visit https://clinicaltrials.gov/study/NCT07467239
Publi...